Spotlight: Danaher and Sherwin-Williams

Our thoughts on Danaher and Sherwin-Williams and how they fit with our Investment Philosophy.

[00:30] Introduction - Anthony summarises what’s happened in US markets since the start of the year.

[02:07] Danaher - Anthony and Josh talk about Danaher’s life sciences and diagnostic businesses.

[06:51] Sherwin-Williams - Paul and Caroline discuss Sherwin-Williams, America’s largest manufacturer and distributor of paint and coatings.

This is a marketing communication. For investment professionals only. Information presented, including any reference to specific investments, is for illustrative purposes only and should not be regarded as investment advice, research or as a recommendation to buy or sell any investments. Past performance is not a reliable indicator of future results. The value of investments may go down as well as up, and you may not get back the original amount invested. This information reflects opinions based on current market conditions at the date of recording. They are subject to change without notice and involve a number of assumptions which may not prove valid. This data is provided for information only and should not be reproduced, published or disseminated in any manner. The podcast is not directed at or intended for distribution to any person or entity who is a citizen, resident or located in any jurisdiction where the distribution of this podcast and/or the purchase or sale of shares in Findlay Park Funds plc (“Fund”) would be contrary to applicable law or regulation. Any investment in the Fund will be subject to the terms, including a list of risk factors referred to in the Fund’s prospectus. Findlay Park accepts no liability for any loss or damage arising from the use or misuse of, or reliance on, the information provided including, without limitation, any loss of profits or any other damage, whether direct or consequential. Findlay Park does not warrant the accuracy, adequacy or completeness of the information and data contained in this podcast. The podcast may include information derived from third parties. All rights for third parties and Findlay Park Partners LLP are reserved.

© Findlay Park Partners LLP 2023.